<- Go Home
Oxford Immunotec Global Limited
As of March 8, 2021, operates as a subsidiary of PerkinElmer (UK) Holdings Limited.
Market Cap
$562.5M
Volume
177.3K
Cash and Equivalents
$160.6M
EBITDA
-$16.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$43.0M
Profit Margin
75.08%
52 Week High
$23.11
52 Week Low
$8.37
Dividend
N/A
Price / Book Value
2.98
Price / Earnings
-34.41
Price / Tangible Book Value
3.03
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$17.9M
Return on Equity
8.19%
Return on Assets
-4.99
Cash and Short Term Investments
$160.6M
Debt
$8.9M
Equity
$191.3M
Revenue
$57.3M
Unlevered FCF
-$7.2M
Sector
Health Care Equipment and Supplies
Category
N/A